Pseudomyxoma peritonei: Is disease progression related to microbial agents? A study of bacteria, MUC2 and MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis

Annals of Surgical Oncology

Volumn 15, Issue 5, 2008, Pages 1414-1423

  Semino Mora, Cristina ^a   Liu, Hui ^a   McAvoy, Thomas ^a,b   Nieroda, Carol ^a,c   Studeman, Kimberley ^c   Sardi, Armando ^c   Dubois, Andre ^a  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c Mercy Health Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 2; MUCIN 5AC;

ARTICLE; CANCER SURGERY; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISSEMINATED PERITONEAL ADENOMUCINOSIS; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; PERITONEAL MUCINOUS CARCINOMATOSIS; PERITONEUM METASTASIS; PERITONEUM PSEUDOMYXOMA; PROTEIN EXPRESSION;

ADENOCARCINOMA, MUCINOUS; APPENDIX; CASE-CONTROL STUDIES; DISEASE PROGRESSION; DNA PROBES; GENE EXPRESSION REGULATION, NEOPLASTIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IN SITU HYBRIDIZATION; MICROSCOPY, ELECTRON, TRANSMISSION; MUCINS; PERITONEAL NEOPLASMS; PROGNOSIS; PSEUDOMYXOMA PERITONEI; RNA PROBES; TUMOR MARKERS, BIOLOGICAL;

EID: 41549093645     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9778-9     Document Type: Article

References (41)

1. Bradley RF, Stewart JH, Russell GB, et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol 2006;30:551-9
2. Mann WJ Jr., Wagner J, Chumas J, et al. The management of pseudomyxoma peritonei. Cancer 1990;66:1636-40
3. Aho AJ, Heinonen R, Lauren P. Benign and malignant mucocele of the appendix. Histological types and prognosis. Acta Chir Scand 1973;139:392-400
4. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van CF, Zoetmulder FA. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458-63
5. Galani E, Marx GM, Steer CB, et al. Pseudomyxoma peritonei: the 'controversial' disease. Int J Gynecol Cancer 2003;13:413-8
6. Loungnarath R, Causeret S, Bossard N, et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 2005;48:1372-9
7. Loungnarath R, Causeret S, Brigand C, et al. [Pseudomyxoma peritonei: new concept and new therapeutic approach]. Ann Chir 2005;130:63-9
8. Levine EA, Stewart JH, Russell GB, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: experience with 501 procedures. J Am Coll Surg 2007;204:943-53
9. Gough DB, Donohue JH, Schutt AJ, et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994;219:112-9
10. Shen P, Hawksworth J, Lovato J, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004;11:178-86
11. Yan H, Pestieau SR, Shmookler BM, et al. Histopathologic analysis in 46 patients with pseudomyxoma peritonei syndrome: failure versus success with a second-look operation. Mod Pathol 2001;14:164-71
12. Semino-Mora C, Doi SQ, Marty A, et al. Intracellular and interstitial expression of H. pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis 2003;187:1165-77
13. O'Connell JT, Tomlinson JS, Roberts AA, et al. Pseudomyxoma peritonei is a disease of MUC2-expressing goblet cells. Am J Pathol 2002;161:551-64
14. O'Connell JT, Hacker CM, Barsky SH. MUC2 is a molecular marker for pseudomyxoma peritonei. Mod Pathol 2002;15:958-72
15. Li JD, Dohrman AF, Gallup M, et al. Transcriptional activation of mucin by Pseudomonas aeruginosa lipopolysaccharide in the pathogenesis of cystic fibrosis lung disease. Proc Natl Acad Sci USA 1997;94:967-72
16. Dohrman A, Miyata S, Gallup M, et al. Mucin gene (MUC 2 and MUC 5AC) upregulation by Gram-positive and Gram-negative bacteria. Biochim Biophys Acta 1998;1406:251-9
17. Souei-Mhiri M, Tlili-Graies K, Ben CL, et al. Mucocele of the appendix. Retrospective study of 10 cases. J Radiol 2001;82:463-8
18. Kuroki Y, Otagiri S, Tsukada K. Disseminated peritoneal adenomucinosis associated with a panperitonitis-like onset: report of a case. Surg Today 2001;31:646-50
19. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol 1995;19:1390-408
20. Tummuru MK, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production. Infect Immun 1993;61:1799-809
21. Lan Z-D, Dai L, Zhuo X-L, et al. Gene cloning and sequencing of BmK AS and BmK AS-1, two novel neurotoxins from the scorpion Butus martensi Karsch. Toxicon 1999;37:815-23
22. Bendayan M, Nanci A, Kan FW. Effect of tissue processing on colloidal gold cytochemistry. J Histochem Cytochem 1987;35:983-96
23. Olivero OA, Chang PK, Lopez-Larraza DM, et al. Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA. Mutat Res 1997;391:79-86
24. Semino-Mora C, Dalakas MC. Rimmed vacuoles with beta-amyloid and ubiquitinated filamentous deposits in the muscles of patients with long-standing denervation (postpoliomyelitis muscular atrophy): similarities with inclusion body myositis. Hum Pathol 1998;29:1128-33
25. Stirling JW, Graff PS. Antigen unmasking for immunoelectron microscopy: labeling is improved by treating with sodium ethoxide or sodium metaperiodate, then heating on retrieval medium. J Histochem Cytochem 1995;43:115-23
26. Aspholm M, Olfat FO, Norden J, et al. SabA Is the H. pylori hemagglutinin and is polymorphic in binding to sialylated glycans. PLoS Pathog 2006;2:989-1001
27. Necchi V, Candusso ME, Tava F, et al. Intracellular, intercellular and stromal invasion of gastric mucosa, preneoplastic lesions, and cancer by H. pylori. Gastroenterology 2007;132:1009-23
28. Oliveira AG, Rocha GA, Rocha AM, et al. Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease. Helicobacter 2006;11:2-9
29. Thomas JE, Gibson GR, Darboe MK, et al. Isolation of H. pylori from human faeces. Lancet 1992;340:1194-5
30. Luzzi I, Covacci A, Censini S, et al. Detection of a vacuolating cytotoxin in stools from children with diarrhea. Clin Infect Dis 1996;23:101-6
31. Kang W, Rathinavelu S, Samuelson LC, et al. Interferon gamma induction of gastric mucous neck cell hypertrophy. Lab Invest 2005;85:702-15
32. Dabbagh K, Takeyama K, Lee HM, et al. IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. J Immunol 1999;162:6233-7
33. Kim YD, Kwon EJ, Park DW, et al. Interleukin-1beta induces MUC2 and MUC5AC synthesis through cyclooxygenase-2 in NCI-H292 cells. Mol Pharmacol 2002;62:1112-8
34. Thompson MA, Ashton RW, Pitot HC. Mucinous appendiceal adenocarcinoma presenting 5 years after appendectomy. Ann Intern Med 2004;140:E677-8
35. Ohara N, Teramoto K. Successful treatment of pseudomyxoma peritonei with intraperitoneal 10 per cent dextrose, sizofiran and cisplatin. J Obstet Gynaecol 2002;22:223
36. Anonymous. IARC Monograph on the evaluation of carcinogenic risks to humans. Schistosomes, liver flukes and Helicobacter pylori. Lyon, France: International Agency for Research on Cancer;1994
37. Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 2004;287:G7-17
38. Kucharzik T, Maaser C, Lugering A, et al. Recent understanding of IBD pathogenesis: implications for future therapies. Inflamm Bowel Dis 2006;12:1068-83
39. Balish E, Warner T. Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 2002;160:2253-7
40. Wang X, Huycke MM. Extracellular superoxide production by Enterococcus faecalis promotes chromosomal instability in mammalian cells. Gastroenterology 2007;132:551-61
41. Gatalica Z, Loggie B. COX-2 expression in pseudomyxoma peritonei. Cancer Lett 2006;244:86-90